Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Plogmark Medical AB
AB
Active
Org 5593381402
Sten Bergmans Väg 21, 121 46
Johanneshov
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2021
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Plogmark Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
769
795
899
1 008
Staff expenses
−375
−613
−531
−389
EBITDA
343
60
230
423
Depreciation & amort.
—
—
—
—
EBIT
343
60
230
423
Net financials
−0
2
2
1
Profit before tax
257
61
232
320
Tax
−53
−13
−49
−66
Net profit
203
49
183
254
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
576
475
549
788
Equity
228
77
210
314
Long-term debt
—
—
—
—
Short-term debt
262
312
253
284
Total debt
262
312
253
284
Financial ratios
5-year trend
EBITDA-margin
42.0%
This company
15.8%
Market median
+166% vs market
2022
2025
Soliditetsgrad
39.8%
This company
38.2%
Market median
+4% vs market
2022
2025
Egenkapitalforrentning
80.8%
This company
18.4%
Market median
+339% vs market
2022
2025
Nettoresultatgrad
25.2%
This company
8.1%
Market median
+211% vs market
2022
2025
Aktivomsætning
1.28×
This company
1.12×
Market median
+14% vs market
2022
2025
Gæld/egenkapital
1.51×
This company
0.62×
Market median
-144% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-12-31
View
PDF
More on Plogmark Medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
